Bristol Myers Squibb (BMY) Cost of Revenue (2009 - 2026)
Bristol Myers Squibb (BMY) recorded Cost of Revenue of $3.73 billion in Q2 2026, up 10.5% from $3.37 billion a year earlier and up 8.9% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Cost of Revenue (2009 - 2026) Analysis & Trends
On a TTM basis, Bristol Myers Squibb's Cost of Revenue came in at $14.68 billion as of Jun 30, 2026, up 3.6% year-over-year; for FY2025, it came in at $13.94 billion, down 0.2% from FY2024.
- Annual Cost of Revenue has a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- Across earlier years, Cost of Revenue came in at $13.97 billion in FY2024 (+30.6%), $10.69 billion in FY2023 (+5.5%), $10.14 billion in FY2022 (+2.0%) and $9.94 billion in FY2021 (-15.6%).
- Quarterly Cost of Revenue has ranged from $2.29 billion in Q3 2021 to $4.81 billion in Q4 2024 over the past five years.
- On a year-over-year basis, Cost of Revenue rose in seven of the last eight quarters, with growth averaging 15.6%.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 75.3% in Q4 2024, against a decline of 19.0% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.42 billion (Q1 2026), $4.1 billion (Q4 2025) and $3.44 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Bristol Myers Squibb | 125.59 Bn | 76.86 Bn | 9.25 Bn | 3.73 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.73 Bn |
| Mar 31, 2026 | 3.42 Bn |
| Dec 31, 2025 | 4.10 Bn |
| Sep 30, 2025 | 3.44 Bn |
| Jun 30, 2025 | 3.37 Bn |
| Mar 31, 2025 | 3.03 Bn |
| Dec 31, 2024 | 4.81 Bn |
| Sep 30, 2024 | 2.96 Bn |
| Jun 30, 2024 | 3.27 Bn |
| Mar 31, 2024 | 2.93 Bn |
| Dec 31, 2023 | 2.75 Bn |
| Sep 30, 2023 | 2.51 Bn |
| Jun 30, 2023 | 2.88 Bn |
| Mar 31, 2023 | 2.57 Bn |
| Dec 31, 2022 | 2.59 Bn |
| Sep 30, 2022 | 2.35 Bn |
| Jun 30, 2022 | 2.72 Bn |
| Mar 31, 2022 | 2.47 Bn |
| Dec 31, 2021 | 2.36 Bn |
| Sep 30, 2021 | 2.29 Bn |
API Access
Bristol Myers Squibb Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();